<HashMap><database>biostudies-literature</database><scores/><additional><omics_type>Unknown</omics_type><volume>10(12)</volume><submitter>Wakiyama H</submitter><pubmed_abstract>Near-infrared photoimmunotherapy (NIR-PIT) is a new cancer treatment that uses an antibody-photo-absorber conjugate (APC) composed of a targeting monoclonal antibody conjugated with a photoactivatable phthalocyanine-derivative dye, IRDye700DX (IR700). APCs injected into the body can bind to cancer cells where they are activated by local exposure to NIR light typically delivered by a NIR laser. NIR light alters the APC chemical conformation inducing damage to cancer cell membranes, resulting in necrotic cell death within minutes of light exposure. NIR-PIT selectivity kills cancer cells by immunogenic cell death (ICD) with minimal damage to adjacent normal cells thus, leading to rapid recovery by the patient. Moreover, since NIR-PIT induces ICD only on cancer cells, NIR-PIT initiates and act</pubmed_abstract><journal>Nanophotonics</journal><pagination>3135-3151</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC9646249</full_dataset_link><repository>biostudies-literature</repository><pubmed_title>Near infrared photoimmunotherapy of cancer; possible clinical applications.</pubmed_title><pmcid>PMC9646249</pmcid><pubmed_authors>Choyke PL</pubmed_authors><pubmed_authors>Kobayashi H</pubmed_authors><pubmed_authors>Kato T</pubmed_authors><pubmed_authors>Furusawa A</pubmed_authors><pubmed_authors>Wakiyama H</pubmed_authors></additional><is_claimable>false</is_claimable><name>Near infrared photoimmunotherapy of cancer; possible clinical applications.</name><description>Near-infrared photoimmunotherapy (NIR-PIT) is a new cancer treatment that uses an antibody-photo-absorber conjugate (APC) composed of a targeting monoclonal antibody conjugated with a photoactivatable phthalocyanine-derivative dye, IRDye700DX (IR700). APCs injected into the body can bind to cancer cells where they are activated by local exposure to NIR light typically delivered by a NIR laser. NIR light alters the APC chemical conformation inducing damage to cancer cell membranes, resulting in necrotic cell death within minutes of light exposure. NIR-PIT selectivity kills cancer cells by immunogenic cell death (ICD) with minimal damage to adjacent normal cells thus, leading to rapid recovery by the patient. Moreover, since NIR-PIT induces ICD only on cancer cells, NIR-PIT initiates and act</description><dates><release>2021-01-01T00:00:00Z</release><publication>2021 Sep</publication><modification>2025-04-21T23:37:06.691Z</modification><creation>2025-04-05T19:11:46.585Z</creation></dates><accession>S-EPMC9646249</accession><cross_references><pubmed>36405499</pubmed><doi>10.1515/nanoph-2021-0119</doi></cross_references></HashMap>